Literature DB >> 3205863

Circulating 'trophoblast' cells in pregnancy have maternal genetic markers.

M T Bertero1, C Camaschella, A Serra, L Bergui, F Caligaris-Cappio.   

Abstract

A syncytiotrophoblast-associated antigen identified by the monoclonal antibody (McAb) H315 is detectable on the surface of a low proportion of peripheral blood cells in pregnant women, raising the possibility of a new approach to prenatal diagnosis of genetic disorders. We aimed at verifying the trophoblastic origin of H315+ cells and their use for prenatal diagnosis of beta-thalassaemia. H315+ cells were separated from the peripheral blood of pregnant women: the DNA obtained from these cells in two selected cases was shown to have genetic markers indistinguishable from those of the mother and definitely different from the fetus. Our results suggest that H315 antigen is expressed by maternal cells and that prenatal diagnosis on peripheral blood of the mother using H315 McAb is not feasible.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3205863     DOI: 10.1002/pd.1970080806

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  4 in total

1.  Overexpression of tissue factor pathway inhibitor 2 attenuates trophoblast proliferation and invasion in preeclampsia.

Authors:  Lili Zheng; Jing Huang; Yuan Su; Fang Wang; Hongfang Kong; Hong Xin
Journal:  Hum Cell       Date:  2020-03-04       Impact factor: 4.174

Review 2.  Non-invasive prenatal diagnosis using fetal cells in maternal blood.

Authors:  Y M Lo
Journal:  J Clin Pathol       Date:  1994-12       Impact factor: 3.411

3.  Isolation of fetal DNA from nucleated erythrocytes in maternal blood.

Authors:  D W Bianchi; A F Flint; M F Pizzimenti; J H Knoll; S A Latt
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

4.  Prenatal Diagnosis of β-Thalassemias and Hemoglobinopathies.

Authors:  Maria Cristina Rosatelli; Luisella Saba
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-11-15       Impact factor: 2.576

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.